Form 10-K · Annual report

Clorox 10-K, filed Aug 7, 2026

Filed
CIK
0000021076
Accession no.
0000021076-26-000034
AI-generated summary

Summary

Clorox completed its acquisition of GOJO in April 2026 and is integrating GOJO into its operations and internal control processes, excluding GOJO from management's assessment of internal control over financial reporting as of June 30, 2026. During fiscal 2026, Clorox transitioned core U.S. operations to a new ERP system and its CEO and CFO concluded disclosure controls and procedures were effective.

Key points

  • Clorox completed its acquisition of GOJO in April 2026 and is integrating GOJO into its operations and internal control processes.
  • Management excluded GOJO from its assessment of internal control over financial reporting as of June 30, 2026.
  • Clorox transitioned core U.S. operations to a new ERP system, completing the transition in the third quarter of fiscal 2026.
  • Ernst & Young LLP audited the effectiveness of Clorox's internal control over financial reporting as of June 30, 2026.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

From the filing

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This information appears under “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in Exhibit 99.1, which is incorporated herein by reference. ITEM 7.A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK This information appears under “Quantitative and Qualitative Disclosures about Market Risk” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in Exhibit 99.1, which is incorporated herein by reference. ITEM 8. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Clorox in Readster

Add Clorox to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.